Board of Tests for Alcohol and Drug Influence; extending sunset date. Effective date. Emergency.
Summary
SB1456 updates and extends the statutory life of the Oklahoma Board of Tests for Alcohol and Drug Influence, re-creating the board through July 1, 2031 under the Oklahoma Sunset Law. The bill keeps the board’s membership structure in place, including representatives from medical schools, public safety, OSBI, health, CLEET, and law enforcement organizations, and continues its authority to appoint a state director and staff as funding allows.
The measure also preserves and restates the board’s core responsibilities: setting uniform standards for breath-alcohol testing, approving methods and equipment, establishing qualifications for test administrators, issuing and revoking permits, and adopting rules for the collection and handling of blood, breath, saliva, and urine specimens. It further authorizes the board to charge fees for incidental operations and maintains a revolving fund in the State Treasury to support board operations.
Impact
SB1456 amends 47 O.S. 2021, Section 759, affecting the statutes governing alcohol and drug testing procedures used in criminal enforcement and administrative license actions. By extending the board’s sunset date and reaffirming its rulemaking and fee authority, the bill continues the legal framework that supports standardized chemical testing for intoxication in Oklahoma, including roadside screening and evidentiary testing.
Sentiment
The bill appears to have broad bipartisan support and little visible opposition. It passed the Senate Public Safety Committee 6-1, then cleared the Senate 48-0, the House Administrative Rules Committee 11-0, and the House floor 77-2. The voting pattern suggests general agreement that the board’s functions are necessary and should continue without interruption.
Contention
There is no committee transcript indicating substantive debate, and the overwhelming votes suggest limited controversy. The only notable dissent came from a small number of legislators in the Senate committee and on the House floor, but the record provided does not identify their concerns. Any potential contention would likely relate to the board’s continued authority over testing standards, permit issuance, and fee-supported operations, but no specific objections are documented in the materials provided.